Azur Pharma, Inc clinical trials
Acquired by Jazz Pharmaceuticals, Jan 18, 2012 · source ↗
The registry lists 1 studies whose lead sponsor is Azur Pharma, Inc. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 19, 2008.
Before and after it joined Jazz Pharmaceuticals
- First submitted before Azur Pharma, Inc became part of Jazz Pharmaceuticals
- 1
- First submitted after Azur Pharma, Inc became part of Jazz Pharmaceuticals
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Azur Pharma, Inc1 study
Something wrong with this grouping? Tell us on the Jazz Pharmaceuticals page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Jazz Pharmaceuticals studies →
- FazaClo Outcomes in the Control of Schizophrenia (FOCUS) Study SurveyCompletedNCT00683891
Sponsor listed in the registry: Azur Pharma, Inc · First submitted before Azur Pharma, Inc became part of Jazz Pharmaceuticals